These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25178985)

  • 41. Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.
    Petrick JL; Hyland PL; Caron P; Falk RT; Pfeiffer RM; Dawsey SM; Abnet CC; Taylor PR; Weinstein SJ; Albanes D; Freedman ND; Gapstur SM; Bradwin G; Guillemette C; Campbell PT; Cook MB
    J Natl Cancer Inst; 2019 Jan; 111(1):34-41. PubMed ID: 29788475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study.
    Sawada N; Iwasaki M; Inoue M; Sasazuki S; Yamaji T; Shimazu T; Tsugane S;
    Cancer Sci; 2010 Dec; 101(12):2652-7. PubMed ID: 20942896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States).
    Tsai CJ; Cohn BA; Cirillo PM; Feldman D; Stanczyk FZ; Whittemore AS
    Cancer Causes Control; 2006 Dec; 17(10):1237-44. PubMed ID: 17111254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
    J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
    Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations between postmenopausal endogenous sex hormones and C-reactive protein: a clearer picture with regional adiposity adjustment?
    Conroy SM; Neilson HK; O'Reilly R; Woolcott CG; Stanczyk FZ; Courneya KS; Friedenreich CM
    Menopause; 2017 Sep; 24(9):1040-1048. PubMed ID: 28640164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.
    Holl K; Lundin E; Surcel HM; Grankvist K; Koskela P; Dillner J; Hallmans G; Wadell G; Olafsdottir GH; Ogmundsdottir HM; Pukkala E; Lehtinen M; Stattin P; Lukanova A
    Int J Cancer; 2009 Jun; 124(12):2923-8. PubMed ID: 19330837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
    Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
    Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
    Manjer J; Johansson R; Berglund G; Janzon L; Kaaks R; Agren A; Lenner P
    Cancer Causes Control; 2003 Sep; 14(7):599-607. PubMed ID: 14575357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating sex hormones play no role in the association between sexual activity and the risk of prostate cancer.
    Ahmadi H; Allameh F; Baradaran N; Montaser-Kouhsari L; Bazargan-Hejazi S; Salem S; Mehrsai A; Pourmand G
    J Sex Med; 2011 Mar; 8(3):905-13. PubMed ID: 21091879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum sex hormone levels are related to breast cancer risk in postmenopausal women.
    Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):583-5. PubMed ID: 9167999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous sex hormones and colorectal cancer survival among men and women.
    Yang W; Giovannucci EL; Hankinson SE; Chan AT; Ma Y; Wu K; Fuchs CS; Lee IM; Sesso HD; Lin JH; Zhang X
    Int J Cancer; 2020 Aug; 147(4):920-930. PubMed ID: 31863463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study.
    Andersson SO; Adami HO; Bergström R; Wide L
    Br J Cancer; 1993 Jul; 68(1):97-102. PubMed ID: 8318428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.
    Gershman B; Shui IM; Stampfer M; Platz EA; Gann PH; Sesso HL; DuPre N; Giovannucci E; Mucci LA
    Eur Urol; 2014 Apr; 65(4):683-9. PubMed ID: 23340241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.